Asset Management One’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-47,190
Closed -$1.49M 1054
2016
Q3
$1.49M Hold
47,190
0.02% 710
2016
Q2
$1.33M Hold
47,190
0.02% 755
2016
Q1
$1.72M Buy
47,190
+30,348
+180% +$1.07M 0.03% 679
2015
Q4
$674K Buy
+16,842
New +$587K 0.01% 994
2015
Q1
Sell
-13,738
Closed -$374K 1349
2014
Q4
$374K Sell
13,738
-4,985
-27% -$119K ﹤0.01% 1089
2014
Q3
$399K Sell
18,723
-13,137
-41% -$301K 0.01% 1066
2014
Q2
$716K Buy
+31,860
New +$742K 0.01% 862

Other funds holding EBS

Asset Management One's EBS Position: Q4 2016 in Review

Asset Management One sold out of Emergent Biosolutions (EBS) in Q4 2016, closing a stake of 47,190 shares — an estimated $1.49M sold.

Asset Management One first reported a position in EBS in Q2 2014 and held it in 7 quarters. The position peaked at $1.72M in Q1 2016. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

  • Asset Management One reported no remaining Emergent Biosolutions position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 47,190 Emergent Biosolutions shares in Q4 2016, an estimated $1.49M.
  • Asset Management One first reported a position in Emergent Biosolutions in Q2 2014 and held it in 7 quarters.
  • Asset Management One's Emergent Biosolutions position peaked at $1.72M in Q1 2016.
  • 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.